Navigation Links
Pulmonary/Respiratory Drug Delivery Market Worth 52.37 Billion USD by 2021
Date:2/20/2017

PUNE, India, February 20, 2017 /PRNewswire/ --

According to a new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period.

Continue Reading
MarketsandMarkets Logo
MarketsandMarkets Logo

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302)

Browse 104 market data Tables and 33 Figures spread through 150 Pages and in-depth TOC on "Pulmonary/ Respiratory Drug Delivery Market"

http://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug-delivery-market-179682410.html

Early buyers will receive 10% customization on this report. 

Growth in this Pulmonary Drug Delivery Market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth.

The Pulmonary Drug Delivery Market is segmented based on formulations, canister type, applications, end users, and regions. On the basis of end user, the market is segmented into hospitals & clinics and homecare settings. The hospitals & clinics segment dominated the market in 2016, this is attributed to the increasing incidence of diseases such as pneumonia and acute exacerbation of COPD (AECOPD) is driving the number of hospitalizations each year.

Inquiry Details: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=179682410

Based on canister type, the market is segmented into plain and coated canister. The coated canister segment is expected to be the fastest growing market in canister type segments in the market during the forecast period. This is attributed to advantages such as robust profile for filling, avoiding crimping, and withstanding the pressure associated with the type of propellant (HFAs or CFCs).

Currently, North America dominates the Pulmonary Drug Delivery Market, and Asia represents the second-largest regional market. North America is further classified as U.S. and Canada.

The U.S. is expected to account for the largest share of the North American Pulmonary Drug Delivery Market in 2016. The large share of this market can be attributed to factors such as growing prevalence of lung and respiratory diseases, technological developments, and the presence of various players focusing on the development of digital inhalers in the country.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=179682410

Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region. Asia is further classified into Japan,India, and China, Japan is expected to account for the largest share of the Asian Pulmonary Drug Delivery Market in 2016. This largest share is attributed to favorable healthcare reimbursement scenarios and insurance coverage. Insurance coverage is mandated by the government and regulated under the Universal Health Insurance System

Prominent players in the Pulmonary Drug Delivery Market include Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

Browse Related Reports: 

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/respiratory-diagnostics-market-163390459.html

About MarketsandMarkets:

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets



'/>"/>
SOURCE MarketsandMarkets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery
2. On-Demand and Delivery Services Applications Expand Into Growing Number of Consumer Based Industries Including Legal Marijuana in Canada
3. Injectable Drug Delivery Market by Type, Therapeutic, Usage Pattern, Administration, Distribution Channel, Patient Care Setting - Forecast to 2021
4. Global Targeted Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts
5. Global Injectable Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts
6. Pulmonary Drug Delivery Devices Market to Reach US$43.05 Billion by 2024: Rising Prevalence of Respiratory Disorders to Drive Growth, Notes TMR
7. Injectable Drug Delivery Market Growing at a CAGR of 11.5% During 2016 to 2021
8. Protein Drugs Market - Forecast (2016-2021) - Growth Driven by Developments in Drug Delivery Systems - Research and Markets
9. Injectable Drug Delivery Market Worth 624.50 Billion USD by 2021
10. Drug Delivery in Central Nervous System Diseases 2016-2021 & 2026: Technologies, Markets and Companies - Profiles of 76 Companies & 98 Collaborations - Research and Markets
11. Cardiovascular Drug Delivery Report 2016-2017 & 2026: Technologies, Markets and Companies - 82 Companies & 80 Collaborations - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2018)... ... August 11, 2018 , ... Award-winning actor and ... on integrative medicine. The episode will go through different integrative medicine options and ... medicine involves using both conventional and complementary approaches to health care in a ...
(Date:8/9/2018)... ... , ... Doctor Snehal Patel is offering the residents of South Fairfax County ... 30th, applicants who are in need of full-arch restorations, but who otherwise couldn’t afford ... Smile Program. , "Our local communities have been very good to us and we ...
(Date:8/7/2018)... (PRWEB) , ... August 07, 2018 , ... Braun Ambulances ... August 8th-10th at Kay Bailey Hutchison Convention Center in Dallas, Texas. Braun Ambulances will ... models and one Liberty model. , Fire Rescue International (FRI) is the International ...
Breaking Medicine Technology:
(Date:8/15/2018)... Fla. (PRWEB) , ... August 15, 2018 , ... Today ... on Kickstarter. , Born out of a desire for confidence and ... sweat marks and body odor – even in the hottest, most humid of climates. ...
(Date:8/14/2018)... ... 2018 , ... Kathy Mills Chang, the founder and CEO ... The ChiroTouch Conference is a one-day learning event hosted in conjunction with The ... have Kathy Mills Chang lead the conference. Kath Mills Chang has provided chiropractors ...
(Date:8/14/2018)... ... ... Eagle Merchant Partners and JLM Financial Partners have closed ... recreational surfacing products across the country. , The move capitalizes on the rapidly-growing ... of markets and customers. Founded in 1998, Recreational Group has grown to more ...
(Date:8/11/2018)... ... 2018 , ... Johns Hopkins All Children’s Hospital will make a broader commitment ... population health perspective on care. At its core, this perspective focuses on ways to ... right facility or setting at the right cost. Mark Douglas "Doug" Baker, M.D., will ...
(Date:8/9/2018)... ... 2018 , ... Lyme disease is one of the fastest growing epidemics to ... – a 25-fold increase since surveillance began in 1982. According to a new report ... states and the District of Columbia. Yet, Lyme and other insect borne illnesses are ...
Breaking Medicine News(10 mins):